Menu

Report Library

All Reports

How Pharma Copes with the Pain of Developing Abuse-Deterrent Opioids

January 16, 2015

With the wide availability of generic opioid analgesics, such as oxycodone and hydromorphone, the abuse of prescription opioids has become a major public health problem in the US. Citeline analyst, Heidi Chen, PhD, examines how pharma copes with the pain of developing abuse-deterrent opiods. For more information about Citeline, or to view their other white paper reports, please visit Citeline here. For the full report, please download the PDF version at the top of this page.
Disease Group Covered: Neurology
Indications Covered: Guillain-Barré Syndrome
Ischemic Stroke
Post-Traumatic Stress Disorder (PTSD)
Premenstrual Dysphoric Disorder (PMDD)
Sleep Apnea
Smoking Cessation
Substance Use Disorder